DIMETHYLAMINOCHELIOLIDE FUMARATE HYDRATE AND METHOD FOR PREPARATION THEREOF, AND USE THEREOF Russian patent published in 2024 - IPC C07D307/93 A61K31/343 A61K31/365 A61P35/00 A61P35/02 

Abstract RU 2824144 C1

FIELD: chemistry.

SUBSTANCE: invention relates to a method of producing dimethylaminomicheliolide fumarate hydrate, characterized by that the hydrate is in crystalline form D, the molar ratio of dimethylaminomicheliolide fumarate to water is 1:1, and the hydrate has molecular formula C17H27NO3⋅C4H4O4⋅H2O. Thermogravimetric analysis shows a weight loss of 3.97–4.22% before decomposition, a differential scanning calorimetry graph shows an endothermic peak of dehydration at 75±5°C and characteristic melting peak at 148±5°C. Hydrate has characteristic peaks at angles 2θ 7.8±0.2°, 11.1±0.2°, 11.4±0.2°, 12.6±0.2°, 12.9±0.2°, 14.4±0.2°, 15.3±0.2°, 17.0±0.2°, 18.7±0.2°, 19.7±0.2°, 20.6±0.2°, 21.0±0.2°, 22.5±0.2°, 23.7±0.2°, 24.3±0.2°, 25.5±0.2° and 26.2±0.2° in X-ray powder diffraction pattern using Cu-Kα radiation. Crystalline form D is in an orthorhombic crystallographic system and has space group P212121, cell parameter a = 8.8346(18) Å, b = 14.796(3) Å, c= 16.385(3) Å, α = 90°, β = 90° and γ = 90°; and cell volume 2141.8 (8) Å3.. The method is carried out by active crystallization, where dimethylaminomicheliolide and fumaric acid are added to a mixed solvent system consisting of solvent S1 and solvent S2 under the action of stirring, at a constant temperature of 30–70°C, wherein the weight ratio of the solvent S2 to the solvent S1 is (0–3):1, and the molar ratio of dimethylaminomicheliolide to fumaric acid is (1–1.6):1; after 5–10 hours of reaction, the reaction mixture is filtered and the residue is dried at 25–45°C at normal pressure for 6–10 hours to obtain dimethylaminomicheliolide fumarate in crystalline form D. Solvent S1 is a mixed solvent consisting of water and any of acetone, tetrahydrofuran, 1,4-dioxane, acetonitrile and methyl isobutyl ketone; solvent S2 is a mixed solvent consisting of an ester and an ether; ester solvent can be selected from any one or two of methyl acetate, ethyl acetate, hexyl acetate and isopropyl acetate; ether solvent can be selected from any one or two of diethyl ether, methyl-ethyl ether, methyl-tert-butyl ether, dipropyl ether, dibutyl ether, dimethyl ether of ethylene glycol, monomethyl ether of ethylene glycol, 1,4-dioxane, tetrahydrofuran and 2-methyltetrahydrofuran.

EFFECT: high output of dimethylamine cheliolide fumarate hydrate with high crystallinity, high bulk density, good fluidity and stability.

3 cl, 6 dwg, 2 tbl, 16 ex

Similar patents RU2824144C1

Title Year Author Number
NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID 2011
RU2612556C2
POLYMORPH MALEATE OF DIPEPTIDYL PEPTIDASE INHIBITOR IV (DPPIV) AND A METHOD FOR PRODUCTION THEREOF 2017
  • Liu, Hong
  • Wang, Jiang
  • Li, Jian
  • Li, Jia
  • Li, Jingya
  • Jiang, Hualiang
  • Luo, Xiaomin
  • Chen, Kaixian
RU2732577C1
CRYSTALLINE POLYMORPHYL OF 4-[5-(PYRIDINE-4-YL)-1H-1,2,4-TRIAZOL-3-YL]-PYRIDINE-2-CARBONITRILE AND METHOD OF ITS OBTAINING 2013
  • Ivabuti Josiyuki
  • Miyata Satikho
  • Sato Takakhiro
  • Uda Dzunitiro
  • Kandou Takamitsu
  • Inoue Tadasi
  • Nakano Khiroyuki
RU2639149C2
CRYSTALLINE FORMS OF THE TLR7/TLR8 INHIBITOR 2019
  • Bieri, Nicole
  • Kordikowski, Andreas
  • Li, Bin
  • Lustenberger, Philipp
  • Ramos, Rita
  • Sethuraman, Vijay
  • Zhang, Sisi
RU2792005C2
CRYSTALLINE FORMS OF (R)-5-[3-CHLORO-4-(2, 3-DIHYDROXYPROPOXY)BEZ[Z]ILIDEN]-2-([Z]-PROPYLIMINO)-3-o-TOLYLTHIAZOLIDIN-4-ONE 2009
  • Nikolas Bonkhem
  • Shtefan Bukhmann
  • Aleks Ehberlin
  • Kristof Imboden
  • Markus Fon-Raumer
RU2519548C2
2-[4-(METHYLAMINOMETHYL)PHENYL]-5-FLUORO-BENZOFURAN-7-CARBOXAMIDE HYDROCHLORIDE POLYMORPHOUS, METHOD FOR ITS PRODUCTION AND APPLICATION 2018
  • Yang, Chunhao
  • Miao, Zehong
  • Tan, Cun
  • Huan, Xiajuan
  • Ding, Jian
  • Chen, Yi
RU2783418C1
MONOSEBACATE OF PYRAZOLE DERIVATIVE 2008
  • Takeuti Khideki
  • Tsuru Ejdzi
RU2482122C2
SALT FORM OF ISOQUINOLINONE TYPE COMPOUND AS ROCK INHIBITOR AND METHOD FOR ITS PREPARATION 2021
  • Ge, Jian
  • Wang, Yandong
  • Liu, Yizhi
  • Wu, Lingyun
  • You, Xu
  • Xiao, Zheming
  • Chen, Shuhui
RU2821792C1
BILASTIN CRYSTALLINE FORMS AND THEIR PRODUCTION METHODS 2016
  • Del Rio Pericacho, Jose Luis
  • Puigjaner Vallet, Maria Cristina
  • Prohens Lopez, Rafael
  • Arredondo Martinez, Yolanda Esther
RU2772222C2
NEW POLYCRYSTALLINE FORM OF TENOFOVIR PRODRUG AND METHOD FOR PRODUCTION THEREOF AND USE THEREOF 2015
  • Chen Min
  • Tyan Chenyao
  • Chzhao Minli
  • Yuj Tszyun
  • Yan Baokhaj
  • Lu Ajfen
RU2701728C2

RU 2 824 144 C1

Authors

Li, Chzhunkhua

Gun, Tszyunbo

Khou, Baokhun

Vu, Sungu

Chen, Yue

Tsyu, Chuantszyan

Chzhu, Sinkhua

Tsi, Tsze

Van, Gujyan

Dates

2024-08-06Published

2020-03-26Filed